Health Care & Hospital Law,
Civil Litigation
Apr. 21, 2021
Opioid makers argue for separate consideration in trial
With 200 people watching the Orange County trial via Zoom, attorneys for four Teva Pharmaceuticals, Endo Pharmaceuticals Inc., Allergan PLC and Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. continued opening statements against false advertising allegations.
Drug companies accused jointly of contributing to the state's opioid epidemic, said they should be treated as separate entities in day two of a $50 billion civil bench trial in Los Angeles.
The plaintiffs are four municipalities that say opioid giant Purdue Pharma and others misleadingly downplayed addiction risks.
Claims against Purdue Pharma, arguably the most criticized pharmaceutical company n...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law
Drug company lawyers grill historian in opioid trial
By Blaise Scemama
Civil Litigation
Pharmaceutical CEO’s deposition played in opioid trial
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Objections predominate in opioid trial of 4 pharmaceutical companies
By Blaise Scemama
Civil Litigation
Defense stymies expert testimony and materials in opioid trial
By Blaise Scemama
Civil Litigation
Tennessee judge issues default judgment over discovery violations
By Henrik Nilsson
Health Care & Hospital Law, Civil Litigation
Does state’s opioid deal cut off others ‘at the knees’?
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Opioid makers must face trial on deception allegations, judge rules
By Tyler Pialet
Government, Criminal
San Francisco public defender opposes DA’s fentanyl task force
By Tyler Pialet
